Harness the power of the Aquilion ONE / PRISM Edition and Aquilion Serve SP CT systems wherever and whenever you need them. The design of our mobile medical equipment allows for high-patient throughput, without compromising on patient safety, workflow, or image quality.
Improving healthcare access and transforming care pathways with Mobile CT's dedicated for lung cancer screening. On the go, fast CT imaging, powered by generator or shore power, with the Aquilion ONE / PRISM Edition or Aquilion Serve SP CT systems.
The Aquilion ONE / PRISM Edition is the first wide-area detector CT installed in a mobile unit, enhancing accessibility and addressing a broad spectrum of clinical needs: from routine screenings to detailed scans for oncology, musculoskeletal, cardiovascular, pulmonary, and neurological patients.
Additionally, the Aquilion ONE / PRISM Edition wide-area CT features AI-assisted technologies with a New User Experience*, providing improved workflow automation that boosts consistency and increases efficiency to help clinicians provide a more confident diagnosis.
Increase efficiency, consistency, and throughput with high-quality, low-dose imaging on the Aquilion Serve SP CT scanner. Combine the power of AI-enabled technologies with a redesigned workflow that makes scanning easier than ever to meet all your clinical needs.
Whatever your clinical needs, our mobile CT systems have you covered, with innovative, intelligent and integrated technologies that enable routine screening as well as detailed scans for oncology, musculoskeletal, cardiovascular, pulmonary, and neurological patients.
* Option
1 PIQE is designed to fully utilize the maximum resolution of the detector.
2 Requires New User Experience.
The beam shaping energy filter leverages the photon-attenuating properties of silver to selectively remove low-energy photons from a polychromatic X-ray beam, leaving an optimized energy spectrum.
SilverBeam combined with Advanced intelligent Clear-IQ Engine (AiCE) DLR enables ultra-low dose lung cancer screening.
Surfacide provides an evidence-based, automated UV-C system that data indicate is effective against multi-drug resistant organisms including C.diff, MRSA, VRE, CRE and Acinetobacter. Our approach is different. The Surfacide Helios system utilizes multiple emitters to provide UV-C energy to more exposed areas with more power and efficacy as compared to single emitter systems.
*The reduction of pathogenic bioburden (Please note ALL mentions of disinfection are referring to the reduction of pathogenic bioburden.)
